Description: Alacris - the systems medicine company provides technologies for personalizing medicine to obtain Targeted Therapy against cancer
" + anzeigen + " " + " " + lang[2] + " " + lang[3] + policies + lang[4] + "
The CMTA is a new generation molecular profiling technology that integrates transcriptome (RNAseq) to whole exome and/or genome sequencing. This test significantly enhances the scope of precision oncology diagnostics. more…
The benefits of comprehensive molecular tumor and micorenvironment profiling for treatment recommendations are increasingly recognized, opening up a novel dimension in personalized oncology. more…